Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove the non-inferiority of Rifamycin SV-MMX® versus
Ciprofloxacin for the treatment of adults with traveller's diarrhoea.